25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Molecular Templates Inc
Buy, Hold or Sell?

Let's analyze Molecular Templates Inc together

I guess you are interested in Molecular Templates Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Molecular Templates Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Molecular Templates Inc

I send you an email if I find something interesting about Molecular Templates Inc.

1. Quick Overview

1.1. Quick analysis of Molecular Templates Inc (30 sec.)










1.2. What can you expect buying and holding a share of Molecular Templates Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$0.64
Expected worth in 1 year
$12.39
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$11.75
Return On Investment
5,876,170.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0 - $0.3201
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Molecular Templates Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-101.63 - $58.23
Total Value Per Share
$-100.99 - $58.87

2.2. Growth of Molecular Templates Inc (5 min.)




Is Molecular Templates Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.2m-$15.1m$19.3m459.3%

How much money is Molecular Templates Inc making?

Current yearPrevious yearGrowGrow %
Making money-$8.1m-$92.7m$84.5m1,041.3%
Net Profit Margin-14.2%-469.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Molecular Templates Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#690 / 932

Most Revenue
#141 / 932

Most Profit
#481 / 932

Most Efficient
#338 / 932
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Molecular Templates Inc?

Welcome investor! Molecular Templates Inc's management wants to use your money to grow the business. In return you get a share of Molecular Templates Inc.

First you should know what it really means to hold a share of Molecular Templates Inc. And how you can make/lose money.

Speculation

The Price per Share of Molecular Templates Inc is $0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Molecular Templates Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Molecular Templates Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.64. Based on the TTM, the Book Value Change Per Share is $2.94 per quarter. Based on the YOY, the Book Value Change Per Share is $-12.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Molecular Templates Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.23-616,961.4%-1.23-616,961.4%-14.08-7,041,288.7%-10.88-5,440,378.6%-6.29-3,147,300.7%
Usd Book Value Change Per Share2.941,469,042.6%2.941,469,042.6%-12.27-6,135,743.7%-2.94-1,468,647.7%0.42210,263.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.017,275.3%
Usd Total Gains Per Share2.941,469,042.6%2.941,469,042.6%-12.27-6,135,743.7%-2.94-1,468,647.7%0.44217,538.9%
Usd Price Per Share3.73-3.73-0.33-6.27-4.95-
Price to Earnings Ratio-3.02--3.02--0.02--1.05--0.99-
Price-to-Total Gains Ratio1.27-1.27--0.03-9.46-0.77-
Price to Book Ratio5.83-5.83--0.14-1.60-0.85-
Price-to-Total Gains Ratio1.27-1.27--0.03-9.46-0.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0002
Number of shares5000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.94-2.94
Usd Total Gains Per Share2.94-2.94
Gains per Quarter (5000000 shares)14,690,425.71-14,686,476.67
Gains per Year (5000000 shares)58,761,702.83-58,745,906.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1058761703587616930-58745907-58745917
201175234061175233960-117491813-117491824
301762851081762850990-176237720-176237731
402350468112350468020-234983627-234983638
502938085142938085050-293729533-293729545
603525702173525702080-352475440-352475452
704113319204113319110-411221347-411221359
804700936234700936140-469967253-469967266
905288553255288553170-528713160-528713173
1005876170285876170200-587459067-587459080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.021.00.04.5%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%9.013.00.040.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.021.04.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%9.013.00.040.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Molecular Templates Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.9382.9380%-12.271+518%-2.937+200%0.421+599%
Book Value Per Share--0.6400.6400%-2.298+459%6.595-90%6.562-90%
Current Ratio--0.9680.9680%1.196-19%2.389-59%3.768-74%
Debt To Asset Ratio--0.8810.8810%1.155-24%0.736+20%0.587+50%
Debt To Equity Ratio--7.4017.4010%-+100%2.276+225%1.247+493%
Dividend Per Share----0%-0%-0%0.015-100%
Enterprise Value--4909872.4004909872.4000%-49471487.360+1108%43749477.928-89%46406857.593-89%
Eps---1.234-1.2340%-14.083+1041%-10.881+782%-6.295+410%
Ev To Ebitda Ratio--3.4333.4330%0.618+456%0.197+1645%-0.938+127%
Ev To Sales Ratio--0.0860.0860%-2.504+3023%2.029-96%infnan%
Free Cash Flow Per Share---6.382-6.3820%-14.007+119%-8.952+40%-6.260-2%
Free Cash Flow To Equity Per Share---7.767-7.7670%-14.047+81%-2.640-66%-0.895-88%
Gross Profit Margin--1.8511.8510%1.000+85%1.170+58%1.085+71%
Intrinsic Value_10Y_max--58.226--------
Intrinsic Value_10Y_min---101.633--------
Intrinsic Value_1Y_max---3.660--------
Intrinsic Value_1Y_min---9.358--------
Intrinsic Value_3Y_max---3.762--------
Intrinsic Value_3Y_min---28.999--------
Intrinsic Value_5Y_max--4.861--------
Intrinsic Value_5Y_min---49.457--------
Market Cap1316.776-1864900%24557872.40024557872.4000%2159512.640+1037%41284877.928-41%32599357.593-25%
Net Profit Margin---0.142-0.1420%-4.694+3211%-0.977+589%-1.955+1279%
Operating Margin---0.096-0.0960%-4.449+4551%-0.914+855%-1.619+1592%
Operating Ratio--1.2221.2220%5.894-79%5.542-78%5.328-77%
Pb Ratio0.000-1864900%5.8305.8300%-0.143+102%1.603+264%0.848+587%
Pe Ratio0.000+100%-3.023-3.0230%-0.023-99%-1.055-65%-0.991-67%
Price Per Share0.000-1864900%3.7303.7300%0.328+1037%6.271-41%4.951-25%
Price To Free Cash Flow Ratio0.000+100%-0.584-0.5840%-0.023-96%-0.935+60%-1.252+114%
Price To Total Gains Ratio0.000-1864900%1.2701.2700%-0.027+102%9.460-87%0.768+65%
Quick Ratio--0.6800.6800%1.575-57%3.399-80%5.269-87%
Return On Assets---0.230-0.2300%-0.950+314%-0.248+8%-0.220-4%
Return On Equity---1.929-1.9290%--100%-0.409-79%-0.278-86%
Total Gains Per Share--2.9382.9380%-12.271+518%-2.937+200%0.435+575%
Usd Book Value--4212000.0004212000.0000%-15132000.000+459%43422000.000-90%43206300.000-90%
Usd Book Value Change Per Share--2.9382.9380%-12.271+518%-2.937+200%0.421+599%
Usd Book Value Per Share--0.6400.6400%-2.298+459%6.595-90%6.562-90%
Usd Dividend Per Share----0%-0%-0%0.015-100%
Usd Enterprise Value--4909872.4004909872.4000%-49471487.360+1108%43749477.928-89%46406857.593-89%
Usd Eps---1.234-1.2340%-14.083+1041%-10.881+782%-6.295+410%
Usd Free Cash Flow---42020000.000-42020000.0000%-92222000.000+119%-58941400.000+40%-41211800.000-2%
Usd Free Cash Flow Per Share---6.382-6.3820%-14.007+119%-8.952+40%-6.260-2%
Usd Free Cash Flow To Equity Per Share---7.767-7.7670%-14.047+81%-2.640-66%-0.895-88%
Usd Market Cap1316.776-1864900%24557872.40024557872.4000%2159512.640+1037%41284877.928-41%32599357.593-25%
Usd Price Per Share0.000-1864900%3.7303.7300%0.328+1037%6.271-41%4.951-25%
Usd Profit---8124000.000-8124000.0000%-92718000.000+1041%-28955400.000+256%-20006000.000+146%
Usd Revenue--57306000.00057306000.0000%19754000.000+190%30820200.000+86%25542900.000+124%
Usd Total Gains Per Share--2.9382.9380%-12.271+518%-2.937+200%0.435+575%
 EOD+2 -6MRQTTM+0 -0YOY+32 -65Y+19 -1910Y+16 -23

3.3 Fundamental Score

Let's check the fundamental score of Molecular Templates Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-0.142
Operating Margin (MRQ)Greater than0-0.096
Quick Ratio (MRQ)Greater than10.680
Current Ratio (MRQ)Greater than10.968
Debt to Asset Ratio (MRQ)Less than10.881
Debt to Equity Ratio (MRQ)Less than17.401
Return on Equity (MRQ)Greater than0.15-1.929
Return on Assets (MRQ)Greater than0.05-0.230
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Molecular Templates Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.269
Ma 20Greater thanMa 500.060
Ma 50Greater thanMa 1000.263
Ma 100Greater thanMa 2000.679
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Molecular Templates Inc

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Fundamental data was last updated by Penke on 2025-01-23 00:11:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Molecular Templates Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -14.2% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Molecular Templates Inc:

  • The MRQ is -14.2%. The company is making a huge loss. -2
  • The TTM is -14.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-14.2%0.0%
TTM-14.2%YOY-469.4%+455.2%
TTM-14.2%5Y-97.7%+83.5%
5Y-97.7%10Y-195.5%+97.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.2%-104.6%+90.4%
TTM-14.2%-211.9%+197.7%
YOY-469.4%-209.8%-259.6%
5Y-97.7%-354.1%+256.4%
10Y-195.5%-489.2%+293.7%
4.3.1.2. Return on Assets

Shows how efficient Molecular Templates Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • -23.0% Return on Assets means that Molecular Templates Inc generated $-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Molecular Templates Inc:

  • The MRQ is -23.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.0%TTM-23.0%0.0%
TTM-23.0%YOY-95.0%+72.1%
TTM-23.0%5Y-24.8%+1.9%
5Y-24.8%10Y-22.0%-2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.0%-12.6%-10.4%
TTM-23.0%-13.0%-10.0%
YOY-95.0%-12.4%-82.6%
5Y-24.8%-13.7%-11.1%
10Y-22.0%-15.8%-6.2%
4.3.1.3. Return on Equity

Shows how efficient Molecular Templates Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • -192.9% Return on Equity means Molecular Templates Inc generated $-1.93 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Molecular Templates Inc:

  • The MRQ is -192.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -192.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-192.9%TTM-192.9%0.0%
TTM-192.9%YOY--192.9%
TTM-192.9%5Y-40.9%-152.0%
5Y-40.9%10Y-27.8%-13.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-192.9%-16.8%-176.1%
TTM-192.9%-17.8%-175.1%
YOY--16.4%+16.4%
5Y-40.9%-20.6%-20.3%
10Y-27.8%-21.3%-6.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Molecular Templates Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Molecular Templates Inc is operating .

  • Measures how much profit Molecular Templates Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • An Operating Margin of -9.6% means the company generated $-0.10  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Molecular Templates Inc:

  • The MRQ is -9.6%. The company is operating very inefficient. -2
  • The TTM is -9.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-9.6%0.0%
TTM-9.6%YOY-444.9%+435.3%
TTM-9.6%5Y-91.4%+81.8%
5Y-91.4%10Y-161.9%+70.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-201.1%+191.5%
TTM-9.6%-321.1%+311.5%
YOY-444.9%-224.0%-220.9%
5Y-91.4%-371.8%+280.4%
10Y-161.9%-506.8%+344.9%
4.3.2.2. Operating Ratio

Measures how efficient Molecular Templates Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are $1.22 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Molecular Templates Inc:

  • The MRQ is 1.222. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.222. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.222TTM1.2220.000
TTM1.222YOY5.894-4.672
TTM1.2225Y5.542-4.321
5Y5.54210Y5.328+0.214
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2222.171-0.949
TTM1.2223.241-2.019
YOY5.8943.239+2.655
5Y5.5424.839+0.703
10Y5.3286.444-1.116
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Molecular Templates Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Molecular Templates Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.97 means the company has $0.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.968. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.968. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.968TTM0.9680.000
TTM0.968YOY1.196-0.228
TTM0.9685Y2.389-1.421
5Y2.38910Y3.768-1.378
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9683.609-2.641
TTM0.9683.842-2.874
YOY1.1964.609-3.413
5Y2.3895.917-3.528
10Y3.7686.176-2.408
4.4.3.2. Quick Ratio

Measures if Molecular Templates Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.68 means the company can pay off $0.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.680. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.680. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.680TTM0.6800.000
TTM0.680YOY1.575-0.895
TTM0.6805Y3.399-2.719
5Y3.39910Y5.269-1.870
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6803.011-2.331
TTM0.6803.349-2.669
YOY1.5754.298-2.723
5Y3.3995.936-2.537
10Y5.2696.457-1.188
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Molecular Templates Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Molecular Templates Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Molecular Templates Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.88 means that Molecular Templates Inc assets are financed with 88.1% credit (debt) and the remaining percentage (100% - 88.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.881. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.881. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY1.155-0.274
TTM0.8815Y0.736+0.145
5Y0.73610Y0.587+0.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.342+0.539
TTM0.8810.342+0.539
YOY1.1550.312+0.843
5Y0.7360.365+0.371
10Y0.5870.385+0.202
4.5.4.2. Debt to Equity Ratio

Measures if Molecular Templates Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 740.1% means that company has $7.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Molecular Templates Inc:

  • The MRQ is 7.401. The company is unable to pay all its debts with equity. -1
  • The TTM is 7.401. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.401TTM7.4010.000
TTM7.401YOY-+7.401
TTM7.4015Y2.276+5.125
5Y2.27610Y1.247+1.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4010.393+7.008
TTM7.4010.430+6.971
YOY-0.383-0.383
5Y2.2760.441+1.835
10Y1.2470.490+0.757
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Molecular Templates Inc generates.

  • Above 15 is considered overpriced but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A PE ratio of -3.02 means the investor is paying $-3.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Molecular Templates Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.023. Based on the earnings, the company is expensive. -2
  • The TTM is -3.023. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-3.023+3.023
MRQ-3.023TTM-3.0230.000
TTM-3.023YOY-0.023-3.000
TTM-3.0235Y-1.055-1.968
5Y-1.05510Y-0.991-0.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.228+2.228
MRQ-3.023-2.733-0.290
TTM-3.023-3.241+0.218
YOY-0.023-3.335+3.312
5Y-1.055-6.499+5.444
10Y-0.991-6.770+5.779
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Molecular Templates Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.584. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.584. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.584+0.584
MRQ-0.584TTM-0.5840.000
TTM-0.584YOY-0.023-0.561
TTM-0.5845Y-0.935+0.351
5Y-0.93510Y-1.252+0.317
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-3.043+3.043
MRQ-0.584-3.763+3.179
TTM-0.584-4.095+3.511
YOY-0.023-4.518+4.495
5Y-0.935-8.387+7.452
10Y-1.252-9.433+8.181
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Molecular Templates Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.83 means the investor is paying $5.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Molecular Templates Inc:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 5.830. Based on the equity, the company is overpriced. -1
  • The TTM is 5.830. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.000MRQ5.830-5.830
MRQ5.830TTM5.8300.000
TTM5.830YOY-0.143+5.973
TTM5.8305Y1.603+4.227
5Y1.60310Y0.848+0.755
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.903-1.903
MRQ5.8302.276+3.554
TTM5.8302.473+3.357
YOY-0.1432.459-2.602
5Y1.6033.669-2.066
10Y0.8484.237-3.389
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Molecular Templates Inc.

4.8.1. Institutions holding Molecular Templates Inc

Institutions are holding 35.005% of the shares of Molecular Templates Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Bellevue Group AG19.43870.0291127982000
2024-09-30SILVERARC CAPITAL MANAGEMENT, LLC9.47520.196862383800
2024-09-30Bvf Inc7.93210.021552223800
2024-09-30Bank of Montreal1.11070.000373125731250
2024-09-30BMO Capital Markets Corp.1.11070.000373125731250
2024-09-30Vanguard Group Inc0.7731050899-9707-16.0166
2024-09-30Geode Capital Management, LLC0.7174047231524012.4789
2024-09-30BlackRock Inc0.579103813000
2024-09-30Invst LLC0.35540.00423400539929.9928
2024-09-30Renaissance Technologies Corp0.21340140532001.4437
2024-09-30State Street Corp0.207701367600
2024-09-30The Carlyle Group Inc0.20250.0021333300
2024-09-30Morgan Stanley - Brokerage Accounts0.07905201-5201-50
2024-09-30PFS Partners, LLC0.05060.0027333300
2024-09-30Tower Research Capital LLC0.04910.00013231-2793-46.3645
2024-09-30Barclays PLC0.007204754750
2024-09-30Advisor Group Holdings, Inc.0.0054035400
2024-09-30Bank of America Corp0.0041027100
2024-09-30TSFG, LLC0.00106600
2024-09-30JPMorgan Chase & Co0.000603700
Total 42.3130.25682785836+139863+5.0%

4.9.2. Funds holding Molecular Templates Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30BB Biotech AG Ord19.43870.0667127982000
2024-11-30Fidelity Extended Market Index0.4421029108-192-0.6553
2024-11-30Fidelity Series Total Market Index0.10660701600
2024-09-30Northern Trust Extended Eq Market Idx0.07690.0001506400
2024-11-30Fidelity Total Market Index0.06020396400
2024-11-30Spartan Extended Market Index Pool E0.0359023651928.8357
2024-11-30Spartan Total Market Index Pool E0.01920126700
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01190.000178110.1282
2024-12-31NT Quality SCC US Fund - L0.0088058100
2024-09-30NT Quality Small Cap Core0.00880.000458100
2024-06-30SSgA U.S. Total Market Index Strategy0.0076050014842.0455
2024-09-30Northern Trust Wilshire 50000.0043028100
2024-11-30Fidelity U.S. Equity Index Ins Trust0.000503400
2024-08-31Guggenheim Active Allocation Fund0.000201400
2024-11-30State St US Ttl Mkt Indx SL Cl I00110
Total 20.22170.06731331377+150+0.0%

5.3. Insider Transactions

Insiders are holding 3.961% of the shares of Molecular Templates Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-14Target N. V. BiotechSELL12798200.66
2024-04-02Target N V BiotechBUY2500002.35
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Working Capital  104,098-40,32763,77137,774101,545-90,32911,216-11,765-549



5.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets35,383
Total Liabilities31,171
Total Stockholder Equity4,212
 As reported
Total Liabilities 31,171
Total Stockholder Equity+ 4,212
Total Assets = 35,383

Assets

Total Assets35,383
Total Current Assets16,772
Long-term Assets18,611
Total Current Assets
Cash And Cash Equivalents 11,523
Net Receivables 250
Other Current Assets 4,999
Total Current Assets  (as reported)16,772
Total Current Assets  (calculated)16,772
+/-0
Long-term Assets
Property Plant Equipment 16,554
Intangible Assets 600
Long-term Assets Other 142
Long-term Assets  (as reported)18,611
Long-term Assets  (calculated)17,296
+/- 1,315

Liabilities & Shareholders' Equity

Total Current Liabilities17,321
Long-term Liabilities13,850
Total Stockholder Equity4,212
Total Current Liabilities
Short-term Debt 2,488
Accounts payable 1,523
Other Current Liabilities 4,279
Total Current Liabilities  (as reported)17,321
Total Current Liabilities  (calculated)8,290
+/- 9,031
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,742
Long-term Liabilities Other 4,108
Long-term Liabilities  (as reported)13,850
Long-term Liabilities  (calculated)13,850
+/-0
Total Stockholder Equity
Common Stock5
Retained Earnings -452,892
Other Stockholders Equity 457,099
Total Stockholder Equity (as reported)4,212
Total Stockholder Equity (calculated)4,212
+/-0
Other
Capital Stock5
Cash and Short Term Investments 11,523
Common Stock Shares Outstanding 4,501
Current Deferred Revenue9,031
Liabilities and Stockholders Equity 35,383
Net Debt 707
Net Invested Capital 4,212
Net Working Capital -549
Property Plant and Equipment Gross 43,602
Short Long Term Debt Total 12,230



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
6,726
41,270
32,213
102,101
57,034
25,814
24,531
48,685
16,204
22,436
89,521
104,118
68,396
53,669
24,283
90,391
140,158
174,202
139,877
192,362
97,548
35,383
35,38397,548192,362139,877174,202140,15890,39124,28353,66968,396104,11889,52122,43616,20448,68524,53125,81457,034102,10132,21341,2706,726
   > Total Current Assets 
6,570
41,061
30,354
100,217
53,357
23,209
22,855
47,657
15,643
20,544
87,650
86,009
66,680
53,170
24,174
60,414
104,863
139,899
101,324
148,215
68,298
16,772
16,77268,298148,215101,324139,899104,86360,41424,17453,17066,68086,00987,65020,54415,64347,65722,85523,20953,357100,21730,35441,0616,570
       Cash And Cash Equivalents 
6,215
40,609
14,339
74,947
28,450
11,404
15,466
8,934
8,691
5,882
11,029
7,279
8,391
9,589
10,551
58,910
87,721
85,451
25,218
24,983
32,190
11,523
11,52332,19024,98325,21885,45187,72158,91010,5519,5898,3917,27911,0295,8828,6918,93415,46611,40428,45074,94714,33940,6096,215
       Short-term Investments 
45
209
14,326
24,707
24,360
11,289
6,871
28,381
6,008
14,408
59,819
58,390
50,209
39,091
13,000
0
10,234
39,633
68,667
118,061
28,859
0
028,859118,06168,66739,63310,234013,00039,09150,20958,39059,81914,4086,00828,3816,87111,28924,36024,70714,32620945
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
15,635
18,094
7,248
1,891
0
0
240
7,508
234
0
0
250
250002347,508240001,8917,24818,09415,6350000000000
       Other Current Assets 
310
243
1,689
563
547
516
518
37,315
944
254
1,167
2,246
832
2,599
623
19
4,424
489
7,205
5,171
7,249
4,999
4,9997,2495,1717,2054894,424196232,5998322,2461,16725494437,3155185165475631,689243310
   > Long-term Assets 
156
209
1,859
1,884
3,677
2,605
1,676
1,028
561
1,892
1,871
18,109
1,716
499
109
29,977
35,295
34,303
38,553
44,147
29,250
18,611
18,61129,25044,14738,55334,30335,29529,9771094991,71618,1091,8711,8925611,0281,6762,6053,6771,8841,859209156
       Property Plant Equipment 
71
199
1,667
1,667
3,169
2,097
1,168
505
271
543
812
686
557
333
109
1,952
6,851
28,117
33,358
27,917
25,764
16,554
16,55425,76427,91733,35828,1176,8511,9521093335576868125432715051,1682,0973,1691,6671,66719971
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
16,364
0
0
0
0
0
1,510
0
8,986
0
0
008,98601,5100000016,36400000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
333
921
28,025
26,623
1,300
1,200
1,100
700
600
6007001,1001,2001,30026,62328,0259213330000000000000
       Long-term Assets Other 
85
10
192
217
508
508
508
523
290
1,349
1,059
1,059
1,159
166
109
1,402
1,821
4,676
5,195
7,244
3,486
142
1423,4867,2445,1954,6761,8211,4021091661,1591,0591,0591,3492905235085085082171921085
> Total Liabilities 
9,393
50,965
58,686
12,733
12,795
6,227
3,117
26,028
11,261
17,953
103,374
127,593
92,372
12,823
4,395
13,102
39,252
71,174
80,537
126,700
112,680
31,171
31,171112,680126,70080,53771,17439,25213,1024,39512,82392,372127,593103,37417,95311,26126,0283,1176,22712,79512,73358,68650,9659,393
   > Total Current Liabilities 
416
884
8,387
9,562
9,658
5,325
2,563
12,874
3,514
8,591
17,451
27,016
25,974
10,828
2,616
10,442
32,509
35,801
37,553
46,670
57,082
17,321
17,32157,08246,67037,55335,80132,50910,4422,61610,82825,97427,01617,4518,5913,51412,8742,5635,3259,6589,5628,387884416
       Short-term Debt 
0
166
331
230
997
909
337
0
0
0
0
0
0
667
7,315
2,400
5,357
14,544
2,211
2,606
2,182
2,488
2,4882,1822,6062,21114,5445,3572,4007,3156670000003379099972303311660
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
667
2,400
2,400
0
800
0
0
0
0
000080002,4002,4006670000000000000
       Accounts payable 
313
281
1,550
1,237
619
1,022
840
284
252
2,389
908
1,689
2,074
725
951
2,517
780
1,465
2,350
1,612
504
1,523
1,5235041,6122,3501,4657802,5179517252,0741,6899082,3892522848401,0226191,2371,550281313
       Other Current Liabilities 
103
603
5,000
6,658
6,605
1,957
1,386
12,590
3,262
6,202
8,007
10,605
9,178
10,103
1,665
2,760
141
2,501
20,400
12,121
8,823
4,279
4,2798,82312,12120,4002,5011412,7601,66510,1039,17810,6058,0076,2023,26212,5901,3861,9576,6056,6585,000603103
   > Long-term Liabilities 
8,977
50,081
50,299
3,171
3,137
902
554
13,154
7,747
9,362
85,923
100,577
66,398
1,995
1,779
2,660
6,743
35,373
42,984
80,030
55,598
13,850
13,85055,59880,03042,98435,3736,7432,6601,7791,99566,398100,57785,9239,3627,74713,1545549023,1373,17150,29950,0818,977
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,165
1,078
3,254
2,940
14,926
35,491
0
0
0035,49114,9262,9403,2541,0783,16500000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
3,961
1,864
53
1,582
3,489
20,750
15,845
34,975
7,199
0
07,19934,97515,84520,7503,4891,582531,8643,961000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
153
53,365
77,156
66,398
1,995
1,779
954
2,673
19,385
4,538
33,350
0
0
0033,3504,53819,3852,6739541,7791,99566,39877,15653,365153000000000
> Total Stockholder Equity
-2,667
-9,695
-26,473
89,368
44,239
19,587
21,414
22,657
4,943
4,483
-13,853
-23,475
-23,976
40,846
19,888
77,289
100,906
103,028
59,340
65,662
-15,132
4,212
4,212-15,13265,66259,340103,028100,90677,28919,88840,846-23,976-23,475-13,8534,4834,94322,65721,41419,58744,23989,368-26,473-9,695-2,667
   Common Stock
0
0
4
37
37
37
15
33
34
49
56
59
63
71
72
27
37
46
50
56
56
5
5565650463727727163595649343315373737400
   Retained Earnings -452,892-444,768-352,050-269,041-164,125-94,704-64,471-353,534-329,440-373,262-351,678-323,263-252,128-226,475-207,793-183,613-165,321-134,657-78,971-34,563-10,997-2,694
   Accumulated Other Comprehensive Income 
-25
-1,383
-16,533
-11,332
-3,982
-831
19
-24
1
-1
11
28
-13
-21
-2
-412
-1,333
18
17
-48
-66
0
0-66-481718-1,333-412-2-21-132811-11-2419-831-3,982-11,332-16,533-1,383-25
   Capital Surplus 
0
0
0
0
0
0
0
0
0
256,563
309,343
328,116
349,236
370,236
373,352
141,733
195,573
267,089
328,314
417,704
0
0
00417,704328,314267,089195,573141,733373,352370,236349,236328,116309,343256,563000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
52
2,685
-7,594
77,533
180,580
187,673
208,758
234,849
236,158
258,312
311,094
330,167
351,531
372,831
375,404
142,145
196,906
267,089
328,314
417,704
429,702
457,099
457,099429,702417,704328,314267,089196,906142,145375,404372,831351,531330,167311,094258,312236,158234,849208,758187,673180,58077,533-7,5942,68552



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue57,306
Cost of Revenue-6,911
Gross Profit50,39550,395
 
Operating Income (+$)
Gross Profit50,395
Operating Expense-63,091
Operating Income-10,466-12,696
 
Operating Expense (+$)
Research Development48,875
Selling General Administrative18,897
Selling And Marketing Expenses6,911
Operating Expense63,09174,683
 
Net Interest Income (+$)
Interest Income1,455
Interest Expense-2,654
Other Finance Cost-1,378
Net Interest Income-2,577
 
Pretax Income (+$)
Operating Income-10,466
Net Interest Income-2,577
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,135-12,797
EBIT - interestExpense = -8,135
-8,135
-5,470
Interest Expense2,654
Earnings Before Interest and Taxes (EBIT)-5,481-5,481
Earnings Before Interest and Taxes (EBITDA)1,430
 
After tax Income (+$)
Income Before Tax-8,135
Tax Provision-27
Net Income From Continuing Ops-26,225-8,162
Net Income-8,124
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,772
Total Other Income/Expenses Net2,3312,577
 

Technical Analysis of Molecular Templates Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Molecular Templates Inc. The general trend of Molecular Templates Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Molecular Templates Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Molecular Templates Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.013 < 0.295 < 0.3201.

The bearish price targets are: .

Tweet this
Molecular Templates Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Molecular Templates Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Molecular Templates Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Molecular Templates Inc. The current macd is -0.08661974.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Molecular Templates Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Molecular Templates Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Molecular Templates Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Molecular Templates Inc Daily Moving Average Convergence/Divergence (MACD) ChartMolecular Templates Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Molecular Templates Inc. The current adx is 22.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Molecular Templates Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Molecular Templates Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Molecular Templates Inc. The current sar is 0.03336044.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Molecular Templates Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Molecular Templates Inc. The current rsi is 26.27. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Molecular Templates Inc Daily Relative Strength Index (RSI) ChartMolecular Templates Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Molecular Templates Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Molecular Templates Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Molecular Templates Inc Daily Stochastic Oscillator ChartMolecular Templates Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Molecular Templates Inc. The current cci is -79.34405151.

Molecular Templates Inc Daily Commodity Channel Index (CCI) ChartMolecular Templates Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Molecular Templates Inc. The current cmo is -56.80074784.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Molecular Templates Inc Daily Chande Momentum Oscillator (CMO) ChartMolecular Templates Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Molecular Templates Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Molecular Templates Inc Daily Williams %R ChartMolecular Templates Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Molecular Templates Inc.

Molecular Templates Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Molecular Templates Inc. The current atr is 0.03759158.

Molecular Templates Inc Daily Average True Range (ATR) ChartMolecular Templates Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Molecular Templates Inc. The current obv is 698,680,172.

Molecular Templates Inc Daily On-Balance Volume (OBV) ChartMolecular Templates Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Molecular Templates Inc. The current mfi is 43.74.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Molecular Templates Inc Daily Money Flow Index (MFI) ChartMolecular Templates Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Molecular Templates Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Molecular Templates Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Molecular Templates Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.269
Ma 20Greater thanMa 500.060
Ma 50Greater thanMa 1000.263
Ma 100Greater thanMa 2000.679
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Molecular Templates Inc with someone you think should read this too:
  • Are you bullish or bearish on Molecular Templates Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Molecular Templates Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Molecular Templates Inc

I send you an email if I find something interesting about Molecular Templates Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Molecular Templates Inc.

Receive notifications about Molecular Templates Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.